Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations

Webster, Lucy, Groskreutz, Derek, Grinbergs-Saull, Anna, Howard, Rob, O’Brien, John T, Mountain, Gail, Banerjee, Sube, Woods, Bob, Perneczky, Robert, Lafortune, Louise, and others. (2017) Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations. Health Technology Assessment, 21 (26). ISSN 1366-5278. (doi:10.3310/hta21260) (KAR id:97753)

PDF Publisher pdf Language: English
Download this file (PDF/6MB)
Request a format suitable for use with assistive technology e.g. a screenreader
Official URL: https://doi.org/10.3310/hta21260

Abstract

There is currently no disease-modifying treatment available to halt or delay the progression of the disease pathology in dementia. An agreed core set of the best-available and most appropriate outcomes for disease modification would facilitate the design of trials and ensure consistency across disease modification trials, as well as making results comparable and meta-analysable in future trials.

Item Type:	Article
DOI/Identification number:	10.3310/hta21260
Subjects:	R Medicine
Divisions:	Divisions > Division for the Study of Law, Society and Social Justice > School of Social Policy, Sociology and Social Research > Centre for Health Services Studies
Depositing User:	Lucy Webster
Date Deposited:	02 Nov 2022 13:23 UTC
Last Modified:	03 Nov 2022 15:09 UTC
Resource URI:	https://kar.kent.ac.uk/id/eprint/97753 (The current URI for this page, for reference purposes)

University of Kent Author Information

Webster, Lucy.

Creator's ORCID:	https://orcid.org/0000-0001-9152-4990
CReDIT Contributor Roles:

Depositors only (login required):

Altmetric

Download Statistics

Total unique views for this document in KAR since July 2020. For more details click on the image.